Beskrivelse
Krav
Fullmektig i Norge:
Org.nummer: 936803911
- Org.nummer:
- Foretaksnavn:
- Foretaksform:
- Næring:
-
Forretningsadresse:
Fullmektig i EP:
2016.04.08, US 201662320316 P
CHRISTOS GEORGIADIS ET AL: "Lentiviral Engineered Fibroblasts Expressing Codon-Optimized COL7A1 Restore Anchoring Fibrils in RDEB", JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 136, no. 1, 1 January 2016 (2016-01-01), pages 284-292, XP055351934, US ISSN: 0022-202X, DOI: 10.1038/JID.2015.364 (B1)
ZURAB SIPRASHVILI ET AL: "Long-Term Type VII Collagen Restoration to Human Epidermolysis Bullosa Skin Tissue", HUMAN GENE THERAPY, vol. 21, no. 10, 1 October 2010 (2010-10-01), pages 1299-1310, XP055352193, US ISSN: 1043-0342, DOI: 10.1089/hum.2010.023 (B1)
E. Mayr ET AL: "Gene Therapy for the COL7A1 Gene" In: "Gene Therapy - Tools and Potential Applications", 27 February 2013 (2013-02-27), InTech, XP055354150, ISBN: 978-953-51-1014-9 DOI: 10.5772/51926, (B1)
ELLIOT WEISS ET AL: "The role of interleukin 10 in the pathogenesis and potential treatment of skin diseases", JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY., vol. 50, no. 5, 1 May 2004 (2004-05-01), pages 657-675, XP055353427, US ISSN: 0190-9622, DOI: 10.1016/j.jaad.2003.11.075 (B1)
JARI HEIKKINEN ET AL: "Dimerization of human lysyl hydroxylase 3 (LH3) is mediated by the amino acids 541 547", MATRIX BIOLOGY, ELSEVIER, NL, vol. 30, no. 1, 8 October 2010 (2010-10-08), pages 27-33, XP028130843, ISSN: 0945-053X, DOI: 10.1016/J.MATBIO.2010.10.002 [retrieved on 2010-10-16] (B1)
JOUNI UITTO ET AL: "Progress toward Treatment and Cure of Epidermolysis Bullosa: Summary of the DEBRA International Research Symposium EB2015", JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 136, no. 2, 1 February 2016 (2016-02-01), pages 352-358, XP055352164, US ISSN: 0022-202X, DOI: 10.1016/j.jid.2015.10.050 (B1)
LU B ET AL: "Topical application of viral vectors for epidermal gene transfer", JOURNAL OF INVESTIGATIVE DERMATOLOGY, ELSEVIER, NL, 1 January 1997 (1997-01-01), pages 803-808, XP002929844, ISSN: 0022-202X, DOI: 10.1111/1523-1747.EP12292254 (B1)
MAKI GOTO ET AL: "Fibroblasts Show More Potential as Target Cells than Keratinocytes in COL7A1 Gene Therapy of Dystrophic Epidermolysis Bullosa", JOURNAL OF INVESTIGATIVE DERMATOLOGY, THE SOCIETY FOR INVESTIGATIVE DERMATOLOGY, vol. 126, 1 January 2006 (2006-01-01), pages 766-772, XP007919621, DOI: 10.1038/SJ.JID.5700117 (B1)
Savita Sankar ET AL: "A Novel Role for Keratin 17 in Coordinating Oncogenic Transformation and Cellular Adhesion in Ewing Sarcoma", MOLECULAR AND CELLULAR BIOLOGY, vol. 33, no. 22, 15 November 2013 (2013-11-15), pages 4448-4460, XP55580057, ISSN: 0270-7306, DOI: 10.1128/MCB.00241-13 (B1)
VÉRONIQUE SALMON-EHR ET AL: "Implication of Interleukin-4 in Wound Healing", LAB INVEST, vol. 80, no. 8, 1 August 2000 (2000-08-01) , pages 1337-1343, XP055353903, (B1)
WO-A1-00/40734 (B1)
WO-A1-2013/121202 (B1)
WO-A1-2015/009952 (B1)
WOLFE D ET AL: "Engineering Herpes Simplex Viral Vectors for Therapeutic Gene Transfer", GENE AND CELL THERAPY: THERAPEUTIC MECHANISMS AND STRATEGIES,, 1 January 2004 (2004-01-01), pages 103-130, XP009115260, (B1)
CRISTINA CHAMORRO ET AL: "Gene Editing for the Efficient Correction of a Recurrent COL7A1 Mutation in Recessive Dystrophic Epidermolysis Bullosa Keratinocytes", MOLECULAR THERAPY - NUCLEIC ACIDS, vol. 5, 1 January 2016 (2016-01-01), page e307, XP055351886, GB ISSN: 2162-2531, DOI: 10.1038/mtna.2016.19 (B1)
Statushistorie
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Varsel om betaling av første årsavgift (3319) (PTEP3377637)
|
Utgående
EP Registreringsbrev (3210) (PTEP3377637)
|
Innkommende, AR376745953
Korrespondanse (Hovedbrev inn)
|
Utgående
EP defect letter
|
Innkommende, AR376735712
Søknadsskjema Patent
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Neste fornyelse/årsavgift:
Betalingshistorikk:
Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
---|---|---|---|---|
Årsavgift 9. avg. år (EP) | 2024.12.11 | 3710 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 8. avg. år (EP) | 2023.12.12 | 2550 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 7. avg. år (EP) | 2022.12.08 | 2200 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 6. avg. år (EP) | 2021.12.09 | 2000 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 5. avg. år (EP) | 2020.12.09 | 1650 | CPA GLOBAL LIMITED | Betalt og godkjent |
32008645 expand_more expand_less | 2020.06.18 | 5500 | CURO AS | Betalt |
Valideringsgebyr EP-patent
5500 = 1 X 5500
|